Upstream deals have flourished in the first quarter of 2022, according to data from Enverus. Compared to the same stretch in 2021 they’ve more than tripled in value. And there are more deals out there, just waiting for commodity prices to stabilize. More on that possibility, along with last week’s transactions, in the CDT Roundup.
CDT Roundup: 13 Deals, 9 Firms, 106 Lawyers, $2.3B
In a week of relatively weak M&A traffic, the increased prominence of healthcare deals is, once again, front and center. The deals these days are not just for healthcare technologies or hospital real estate — the M&A market for professional care itself is becoming abundantly clear. That, and the week’s dealmakers in the CDT Roundup.
Michael Piazza, Advisor for the Oaks, Jumps to Gibson Dunn
For the second time in less than a week, a top corporate partner in Willkie Farr’s Houston office is joining a competitor.
2021 Capital Markets in Texas: An Extraordinary Year ‘Across the Board’
Capital markets deals in Texas were up — way up. The value of those deals were down — way down. But that’s not necessarily a bad thing, say our lawyer/dealmakers. Reduced capital budgets, acquisitions made with a clearer sense of purpose and a broader base of issuers created a market in which IPOs made their comeback — and SPACs made their presence felt.
CDT Roundup: 18 Deals; 11 Firms; 239 Lawyers; $12B
Something paradoxical happened to Texas energy deals in 2020 and 2021: They increased their share of the overall M&A market. This comes after a pandemic and a couple of notable energy disasters. But numbers aren’t always exactly what they seem. The CDT Roundup explores the anomaly along with the weekly roll call of Texas transactions.